Supply Dabigatran Etexilate Powder CAS 211915-06-9
GMP HALAL KOSHER ISO FDA
211915-06-9
99%
Foil Bag, Drum
2022-12-31
Herb Extracts,Cosmetic raw materails,API
-
Product Description
-
Seller Information
-
Description
Product descriptionProduct name:dabigatran etexilate
Synonyms n-(2-(4-(n-(hexyloxycarbonyl)amidino)phenylaminomethyl)-1-methyl-1h-benzimidazol-5-ylcarbonyl)-n-(2-pyridyl)-beta-alanine ethyl ester
CAS No. 211915-06-9
Molecular weight 627.74
Molecular Formula C34H41N7O5
Boiling Point 447.2 °C at 760 mmHg
Appearence White powderFunction & Application
Product name Dabigatran Etexilate
CAS NO. 211915-06-9 Synonyms Dabigatran Etexilate
Category Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals. Purity 99% Dabigatran Etexilate Appearance Dabigatran Etexilate powder
Shelf life 2 years Usage Dabigatran Etexilate is an oral anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in some cases it offers an alternative to warfarin as the preferred orally administered anticoagulant ("blood thinner") since it does not require blood tests for international normalized ratio (INR) monitoring while offering similar results in terms of efficacy.
Storage Dabigatran Etexilate should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Product photos
ECHEMI Editorial ReferenceDabigatran etexilate(BIBR-1048) is the orally active prodrug of dabigatran; Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.IC50 Value: 4.5 nM (Ki); 10 nM(Thrombin-induced platelet aggregation) [1]in vitro: Dabigatran selectively and reversibly inhibited human thrombin(Ki: 4.5 nM) as well as thrombin-induced platelet aggregation (IC(50): 10 nM), while showing no inhibitory effect on other platelet-stimulating agents.Thrombin generation in
Solid
Dabigatran etexilate is an oral prodrug that is hydrolyzed to the competitive and reversible direct thrombin inhibitor [dabigatran]. Dabigatran etexilate may be used to decrease the risk of venous thromboembolic events in patients in whom anticoagulation therapy is indicated. In contrast to warfarin, because its anticoagulant effects are predictable, lab monitoring is not necessary. Dabigatran etexilate was approved by the FDA in 2010.CertificatesBasic Info-
Product Name:
Dabigatran etexilate
Other Name:β-Alanine,N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester;Dabigatran etexilate;BIBR 1048;Prazaxa;1428422-77-8
CAS No.:211915-06-9
Molecular Formula:C34H41N7O5
InChIKeys:InChIKey=KSGXQBZTULBEEQ-UHFFFAOYSA-N
Molecular Weight:627.74
Exact Mass:627.73
EC Number:1592732-453-0
UNII:2E18WX195X
HScode:2933990090
Categories:
Characteristics-
PSA:
152
XLogP3:3.8
Appearance:Solid
Density:1.2±0.1 g/cm3
Melting Point:128-129 °C
Boiling Point:827.9°C at 760 mmHg
Flash Point:454.5±37.1 °C
Refractive Index:1.615
Water Solubility:1.8mg/ml, partly soluble
Vapor Pressure:1.49E-27mmHg at 25°C
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Herb Extracts,Cosmetic raw materails,API
-
Location:
1403,Jinye B Block
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
8
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2015
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product